Fill-Finish & Packaging

Inside Celltrion: a biosimilar success story built on landfill

Dispatches from Korea

Inside Celltrion: a biosimilar success story built on landfill

By Dan Stanton

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.

Best before... Image: StanleyD

Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium

Short shelf-life poses problems for cell therapy makers, Chiesi

By Dan Stanton

The shelf life of a cell therapy product is crucial in determining a firm’s manufacturing strategy according to the makers of the first approved stem-cell based drug.

Unilife plans to fix its finances by selling the company or an asset, or entering a partnership

Unilife undecided on takeover plans; gives December 31 deadline

By Fiona BARRY

Unilife CEO Alan Shortall yesterday confirmed the drug delivery company is still “receiving interest from several parties under the strategic review process” and set a deadline of December 31 to announce any potential takeover.  The company received its...

Sharma plans to add to the company's acquisitions

CPhI Worldwide 2015

Profile of a CEO: Piramal Chief shares M&A plans

By Fiona BARRY

Piramal chief executive Vivek Sharma won last week’s CPhI award for the pharma industry’s CEO of the year. spoke to Sharma about his plans for the CDMO the day after the jury’s unanimous decision.